Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Philip Miller

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Statistics in Biopharmaceutical Research|August 13, 2010
Measuring Study-Specific Heterogeneity in Meta-Analysis: Application to an Antecedent Biomarker Study of Alzheimer's DiseaseChengjie Xiong, J Philip Miller, John C Morris
Journal of Alzheimer'S Disease : JAD|December 4, 2003
Testing correlation of cognitive decline at adjacent stages of dementiaChengjie Xiong, J Philip Miller, John C Morris
Journal of Biopharmaceutical Statistics|March 19, 2004
Effect of a guarantee time on sample size determination for testing the ratio of means from two lifetime distributionsChengjie Xiong, J Philip Miller, Yan Yan, et al.
Neurology|August 9, 2006
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCIMartha Storandt, Elizabeth A Grant, J Philip Miller, et al.
Statistics in Medicine|December 14, 2005
Measuring and estimating diagnostic accuracy when there are three ordinal diagnostic groupsChengjie Xiong, Gerald van Belle, J Philip Miller, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 10, 2004
Combining correlated diagnostic tests: application to neuropathologic diagnosis of Alzheimer's diseaseChengjie Xiong, Daniel W McKeel, J Philip Miller, et al.
Alzheimer Disease and Associated Disorders|September 10, 2002
Relationships among cerebrospinal fluid biomarkers in dementia of the Alzheimer typeJohn G Csernansky, J Philip Miller, Daniel McKeel, et al.
Neurology|October 10, 2002
Rates of progression in mild cognitive impairment and early Alzheimer's diseaseMartha Storandt, Elizabeth A Grant, J Philip Miller, et al.
Clinical Trials (London, England)|February 22, 2011
Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer's diseaseChengjie Xiong, Gerald van Belle, J Philip Miller, et al.
Journal of the Air & Waste Management Association (1995)|May 8, 2009
Air pollution and survival within the Washington University-EPRI veterans cohort: risks based on modeled estimates of ambient levels of hazardous and criteria air pollutantsFrederick W Lipfert, Ronald E Wyzga, Jack D Baty, et al.
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Statistics in Biopharmaceutical Research|August 13, 2010
Measuring Study-Specific Heterogeneity in Meta-Analysis: Application to an Antecedent Biomarker Study of Alzheimer's DiseaseChengjie Xiong, J Philip Miller, John C Morris
Journal of Alzheimer'S Disease : JAD|December 4, 2003
Testing correlation of cognitive decline at adjacent stages of dementiaChengjie Xiong, J Philip Miller, John C Morris
Journal of Biopharmaceutical Statistics|March 19, 2004
Effect of a guarantee time on sample size determination for testing the ratio of means from two lifetime distributionsChengjie Xiong, J Philip Miller, Yan Yan, et al.
Neurology|August 9, 2006
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCIMartha Storandt, Elizabeth A Grant, J Philip Miller, et al.
Statistics in Medicine|December 14, 2005
Measuring and estimating diagnostic accuracy when there are three ordinal diagnostic groupsChengjie Xiong, Gerald van Belle, J Philip Miller, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 10, 2004
Combining correlated diagnostic tests: application to neuropathologic diagnosis of Alzheimer's diseaseChengjie Xiong, Daniel W McKeel, J Philip Miller, et al.
Alzheimer Disease and Associated Disorders|September 10, 2002
Relationships among cerebrospinal fluid biomarkers in dementia of the Alzheimer typeJohn G Csernansky, J Philip Miller, Daniel McKeel, et al.
Neurology|October 10, 2002
Rates of progression in mild cognitive impairment and early Alzheimer's diseaseMartha Storandt, Elizabeth A Grant, J Philip Miller, et al.
Clinical Trials (London, England)|February 22, 2011
Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer's diseaseChengjie Xiong, Gerald van Belle, J Philip Miller, et al.
Journal of the Air & Waste Management Association (1995)|May 8, 2009
Air pollution and survival within the Washington University-EPRI veterans cohort: risks based on modeled estimates of ambient levels of hazardous and criteria air pollutantsFrederick W Lipfert, Ronald E Wyzga, Jack D Baty, et al.
Pageof 17